Published in Verh Dtsch Ges Inn Med on January 01, 1974
Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation (1996) 2.05
Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med (1988) 1.66
Antihypertensive treatment and serum lipoproteins. J Hypertens (1985) 1.54
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol. Br J Clin Pharmacol (1976) 1.53
Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet (1993) 1.47
Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension. N Engl J Med (1988) 1.46
Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study. J Hypertens (2001) 1.40
Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med (1979) 1.30
[Armand Trousseau (1801-1867) and the placebo effect]. Schweiz Med Wochenschr (1986) 1.27
Effect on aging on plasma renin and aldosterone in normal man. Kidney Int (1975) 1.23
Effects of antihypertensive therapy on serum lipoproteins. Hypertension (1983) 1.19
Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion. Am J Cardiol (1978) 1.19
Rate of functional deterioration in polycystic kidney disease. Kidney Int (1983) 1.19
Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest (1986) 1.13
Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine. Kidney Int (1985) 1.12
Clinical use of furosemide. Ann N Y Acad Sci (1966) 1.11
Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Intern Med (1977) 1.11
Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int (1992) 1.09
Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J (1977) 1.08
Effects of nitrendipine and other calcium antagonists on glucose metabolism in man. J Cardiovasc Pharmacol (1984) 1.07
Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med (1991) 1.06
Methicillin nephritis. Medicine (Baltimore) (1977) 1.05
Effect of different degrees of tilt on cardiac output, heart rate, and blood pressure in normal man. Br Heart J (1966) 1.05
Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect? Clin Sci Mol Med Suppl (1978) 1.03
Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens (2001) 1.03
Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med (1972) 1.02
Strong specificity in the interaction between parasitoids and symbiont-protected hosts. J Evol Biol (2012) 1.02
Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int (1977) 1.01
Autonomic function tests as related to age and gender in normal man. Klin Wochenschr (1986) 1.00
Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest (1987) 0.99
[Deep leg vein thrombosis during skiing. A case report]. Schweiz Med Wochenschr (1983) 0.99
Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin. Kidney Int (1981) 0.99
Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med (1971) 0.98
Plasma renin and blood pressure during treatment with methyldopa. Am J Cardiol (1974) 0.98
Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab (1979) 0.96
Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol (1987) 0.95
Calcitonin gene-related peptide is a stimulator of renin secretion. J Clin Invest (1988) 0.95
Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol (1985) (1991) 0.94
Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol (1985) (1988) 0.93
Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects. Klin Wochenschr (1982) 0.93
Insulin, insulin sensitivity and hypertension. J Hypertens (1990) 0.92
Plasma renin activity in patients with coarctation of the aorta. A comment of the pathogenesis prestenotic hypertension. Circulation (1969) 0.92
[The effect of diuretic therapy on serum lipoproteins: an undesirable effect?]. Schweiz Med Wochenschr (1979) 0.91
Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int (1978) 0.91
Hypertension associated with tumors adjacent to renal arteries. Am J Med (1969) 0.91
Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci (Lond) (1982) 0.90
Stimulation of renin secretion by potassium-channel activation with cromakalim. Eur J Clin Pharmacol (1989) 0.90
Size of family and behavioral problems in children. J Genet Psychol (1967) 0.90
Norepinephrine clearance and pressor effect in normal and hypertensive man. Klin Wochenschr (1980) 0.90
Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism (1980) 0.90
Antihypertensive agents, serum lipoproteins and glucose metabolism. Am J Cardiol (1991) 0.89
Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide. Klin Wochenschr (1981) 0.89
Ample genetic variation but no evidence for genotype specificity in an all-parthenogenetic host-parasitoid interaction. J Evol Biol (2010) 0.88
Reproducibility of insulin sensitivity measured by the minimal model method. Diabetologia (1991) 0.88
A scale for assessing suicide risk of attempted suicides. J Clin Psychol (1968) 0.88
Effect of prostaglandin E1 on renin in the dog. Am J Physiol (1971) 0.87
Dysregulation of atrial natriuretic factor in hypertension-prone man. J Clin Endocrinol Metab (1990) 0.87
[The effect of hydrochlorothiazide/amiloride alone or in combination with alpha-methyldopa on serum lipoproteins]. Schweiz Med Wochenschr (1981) 0.87
Dialysis treatment of acute chromium intoxication and comparative efficacy of peritoneal versus hemodialysis in chromium removal. Miner Electrolyte Metab (1982) 0.87
[Drug therapy in hypertension 1977. Empirical and rational viewpoints]. Schweiz Med Wochenschr (1978) 0.87
Role of physical factors in the acute changes in renal function elicited by antihypertensive drugs. Eur J Clin Pharmacol (1978) 0.87
Catecholamines, sodium and renin in unilateral renal hypertension in man. Miner Electrolyte Metab (1982) 0.86
Albumin multiplier in kidney vasa recta analyzed by microspectrophotometry of T-1824. Am J Physiol (1967) 0.86
Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab (1986) 0.86
Factors related to attendance in a center for older people. J Am Geriatr Soc (1967) 0.86
Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. Antimicrob Agents Chemother (1986) 0.85
Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics. J Am Coll Cardiol (1997) 0.85
Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension. J Clin Endocrinol Metab (1979) 0.85
Lasting improvement of renovascular hypertension by transluminal dilatation of atherosclerotic and nonatherosclerotic renal artery stenoses. A follow-up study. Circulation (1982) 0.85
Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man. J Clin Endocrinol Metab (1974) 0.85
Body sodium-blood volume state in nonazotemic diabetes mellitus. Miner Electrolyte Metab (1982) 0.85
Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review. J Hypertens Suppl (1987) 0.85
Pressor factors and cardiovascular pressor responsiveness in borderline hypertension. Hypertension (1981) 0.84
Genotype-by-genotype specificity remains robust to average temperature variation in an aphid/endosymbiont/parasitoid system. J Evol Biol (2013) 0.84
Pathogenesis and treatment of hypertension associated with diabetes. Horm Metab Res Suppl (1985) 0.84
Norepinephrine-related mechanism in hypertension accompanying renal failure. Kidney Int (1985) 0.84
Blood pressure control in normotensive members of hypertensive families. Kidney Int (1986) 0.84
Disturbed noradrenergic blood pressure control in normotensive members of hypertensive families. Br Heart J (1984) 0.83
Renal handling of norepinephrine and epinephrine in the pig. Pflugers Arch (1985) 0.83
Effect of a new somatostatin analogue SMS 201-995 (Sandostatin) on the renin-aldosterone axis. Clin Endocrinol (Oxf) (1988) 0.83
Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension. Kidney Int (1987) 0.83
Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension. Clin Exp Hypertens (1980) 0.83
Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension (1986) 0.82
When log-dwellers meet loggers: impacts of forest fragmentation on two endemic log-dwelling beetles in southeastern Australia. Mol Ecol (2006) 0.82
Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function. Br J Clin Pharmacol (1983) 0.82
Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease. Kidney Int (1982) 0.82
Hypovolemia contributes to the pathogenesis of orthostatic hypotension in patients with diabetes mellitus. Am J Med (1999) 0.82
Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am J Physiol (1990) 0.82
Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus. Klin Wochenschr (1980) 0.82
Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis. Clin Nephrol (1980) 0.82
Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab (1986) 0.82
[Plasma renin activity in pheochromocytoma]. Dtsch Med Wochenschr (1970) 0.82
Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension. Am J Med (1976) 0.81